PodcastIntel
Sign in Get Started Free
The Long Run with Luke Timmerman
The Long Run with Luke Timmerman

Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

Dec 26, 2023 · 01:03:55
Listen to Episode
✨ AI Summary
  • Shelley Force Aldred and Nathan Trinklein on bispecific antibodies.
  • Rondo Therapeutics is developing novel cancer therapies.
  • Leveraging bispecific antibodies for enhanced anti-cancer activity.

Guests on This Episode

NT
Nathan Trinklein
1 podcast appearance
SA
Shelley Force Aldred
researcher (ORCID 0000-0003-2095-7646) · 1 podcast appearance
›

More from The Long Run with Luke Timmerman

The Long Run with Luke Timmerman
Ep211: Ardem Patapoutian on Touch, Pain & New Discoveries in Neuroscience
Oct 7, 2026 · 01:06:37
The Long Run with Luke Timmerman
Ep210: Cameron Turtle on Long-Lasting Antibodies for Immune Disorders
Sep 23, 2026 · 01:03:57
The Long Run with Luke Timmerman
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
Sep 9, 2026 · 01:36:12
The Long Run with Luke Timmerman
Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus
Aug 25, 2026 · 01:07:17
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to The Long Run with Luke Timmerman and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →